系统性红斑狼患者对生物制剂的知识,态度和做法:一个横截面研究
Xue Xu1, Mengru Du1, Peng Lai1
1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Frontiers in public health
|March 26, 2025
概括
系统性红斑狼 (SLE) 患者对生物制剂的知识和被动做法很低. 提高患者对生物疗法的教育对于改善结果至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 患者健康素养 患者健康素养
背景情况:
- 生物疗法为系统性红斑狼 (SLE) 提供了先进的治疗选择.
- 了解患者对生物制剂的知识,态度和做法 (KAP) 对于有效的治疗策略至关重要.
研究的目的:
- 在SLE患者中研究生物药物的KAP.
- 确定与生物疗法相关的主动实践相关的因素.
主要方法:
- 一项涉及南京鼓楼医院543名SLE患者的横截面研究.
- 通过自行设计的调查问卷收集的数据,评估人口信息和KAP.
- 用多变量逻辑回归和结构方程建模进行分析.
主要成果:
- 患有SLE的患者表现出不充分的知识 (平均得分6.08/32),不理想的态度 (33.14/50) 和被动的做法 (12.06/30) 关于生物.
- 更高的知识和积极的态度与积极的实践有显著的关联.
- 知识直接影响了态度和做法;态度直接影响了做法.
结论:
- 患有SLE的患者需要对生物疗法有更好的理解和参与.
- 医疗保健提供者应专注于教育干预措施,以增强知识,培养积极态度,并促进SLE管理中的生物药物的积极实践.
关键词:
我们的态度 态度 态度 态度 态度生物学是生物学的学科.跨截面研究是跨截面研究.知识的知识知识的知识.在实践中,实践实践.系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.更多相关视频
相关概念视频
Factors Affecting Protein-Drug Binding: Patient-Related Factors
33
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
33
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Bioavailability: Overview
2.6K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.6K
Autoimmune Disorders
363
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
363
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106


